Overview

Combined Intravenous Dexamethasone and Dexmedetomidine as Adjuncts to Popliteal and Saphenous Nerve Blocks in Patients Undergoing Orthopaedic Surgery of the Foot and Ankle

Status:
Recruiting

Trial end date:
2024-06-01

Target enrollment:

Participant gender:

Summary

We will investigate the beneficial and harmful effects of combining dexamethasone (12 mg) and dexmedetomidine (1mcg/kg) as adjuncts to popliteal and saphenous nerve blocks in patients undergoing surgery of their foot or ankle.

Phase:

Phase 4

Details

Lead Sponsor:

Zealand University Hospital

Treatments:

BB 1101
Dexamethasone
Dexamethasone acetate
Dexmedetomidine